FARN — Faron Pharmaceuticals Oy Cashflow Statement
0.000.00%
Last trade - 00:00
- £223.90m
- £209.52m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13.3 | -16.9 | -21.2 | -28.7 | -30.9 |
Depreciation | |||||
Non-Cash Items | 0.213 | 0.075 | 0.485 | 1.65 | 4.88 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.28 | -0.901 | -1.82 | 3.79 | 1.91 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -11.5 | -17.5 | -22.2 | -23 | -23.8 |
Capital Expenditures | -0.1 | -0.142 | -0.474 | -0.385 | -0.123 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0.001 | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.1 | -0.142 | -0.473 | -0.385 | -0.123 |
Financing Cash Flow Items | -1.18 | 0.371 | -0.318 | -0.135 | -1.11 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.6 | 14.8 | 25.6 | 23.5 | 24 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.99 | -2.95 | 2.75 | 0.137 | -0.114 |